We are monitoring the impact of COVID-19 on North America Antiviral Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1509
Share on
Share on

North America Antiviral Drugs Market Research Report - Segmented By Application , By Target, By End Users & By Country(U.S, Canada and Rest of North America)- Industry Analysis, Size, Share, Growth, Trends, And Forecasts | 2021 to 2026

Pulished: April, 2021
ID: 1509
Pages: 135

North America Antiviral Drugs Market Size & Growth (2021 to 2026)

As per the research report, the size of the North America Antiviral Drugs Market is valued at USD 14.23 billion in 2021 and is expected to reach USD 17.71 billion by 2026, growing at a CAGR of 4.47% during the forecast period 2021 to 2026.

Antiviral Drugs helps in combating viral infections by hampering the replication of viruses and strengthening the immune response to the viral infection. From the past few years resistance is observed among viruses against different antiviral drugs with increasing diversity of viruses. This challenge leads to the evolution of broad-spectrum antiviral drugs that specifically attack viruses at specified targets such as DNA Polymerase, NS3 Protease, & Reverse Transcriptase. These drugs are used to prevent or cure different viral infections such as HIV/AIDS, Hepatitis, influenza, and other viral infections. North America region is leading market for Antiviral Drugs and the growth trend is likely to continue during the forecast period.

The growth of Antiviral drugs in North American market is majorly driven by factors such as boost in research and development segment, emergence of life-threatening diseases, introduction of innovative drugs, and increase in viral infection incidences. In 2016, approximately 1.5 million people are living with AIDS in North America and outbreak of other viruses primarily Zika and Chikungunya is set to spike the sale of antiviral drugs in North America. The key restraints of the market are high cost involved in drug development, restricted trade policies, and side-effects of products such as nausea, diarrhea, and behavioral changes

This research report segmented and sub-segmented into the following categories:

  • By Application: HIV/AIDS, Hepatitis, Herpes, Influenza, And Others
  • By Target: DNA Polymerase, NS3 Protease, Reverse Transcriptase, And Others
  • By End Users: Hospitals, Research Institutes, And Laboratory Centers
  • By Country: U.S, Canada and Rest of North America

Companies playing a dominant role in the North America Antiviral Drugs Market profiled in this report are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 HIV/AIDS

                                5.1.3 Hepatitis  

                                5.1.4 Herpes     

                                5.1.5 Influenza 

                                5.1.6 Others      

                                5.1.7 Y-o-Y Growth Analysis, By Application         

                                5.1.8 Market Attractiveness Analysis, By Application        

                                5.1.9 Market Share Analysis, By Application         

                5.2 Target                           

                                5.2.1 Introduction           

                                5.2.2 DNA polymerase  

                                5.2.3 NS3 Protease         

                                5.2.4 Reverse transcriptase        

                                5.2.5 Others      

                                5.2.6 Y-o-Y Growth Analysis, By Target   

                                5.2.7 Market Attractiveness Analysis, By Target

                                5.2.8 Market Share Analysis, By Target   

                5.3 End Users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals/Clinics   

                                5.3.3 Research Institutes             

                                5.3.4 Laboratory Centers             

                                5.3.5 Y-o-Y Growth Analysis, By End Users            

                                5.3.6 Market Attractiveness Analysis, By End Users          

                                5.3.7 Market Share Analysis, By End Users            

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Target

                                                6.1.3.4 By End-Users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Target

                                                6.1.4.4 By End-Users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Target

                                                6.1.5.4 By End-Users

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Johnson & Johnson                 

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Novartis International AG                     

                8.3 Roche Holding AG                   

                8.4 Pfizer                            

                8.5 Merck and Co. Inc                    

                8.6 GlaxoSmithKline plc                

                8.7 AstraZeneca AB                        

                8.8 Gilead Sciences                         

                8.9 Abbott Laboratories               

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Antiviral Drugs Market By Application, From 2021 to 2026 ( USD Billion )
  2. North America HIV/AIDS  Market By Region, From 2021 to 2026 ( USD Billion )
  3. North America Hepatitis Market By Region, From 2021 to 2026 ( USD Billion )
  4. North America Herpes Market By Region, From 2021 to 2026 ( USD Billion )
  5. North America Influenza Market By Region, From 2021 to 2026 ( USD Billion )
  6. North America Others Market By Region, From 2021 to 2026 ( USD Billion )
  7. North America Antiviral Drugs Market By Target, From 2021 to 2026 ( USD Billion )
  8. North America DNA polymerase Market By Region, From 2021 to 2026 ( USD Billion )
  9. North America NS3 Protease Market By Region, From 2021 to 2026 ( USD Billion )
  10. North America Reverse transcriptase Market By Region, From 2021 to 2026 ( USD Billion )
  11. North America Others Market By Region, From 2021 to 2026 ( USD Billion )
  12. North America Antiviral Drugs Market By End User, From 2021 to 2026 ( USD Billion )
  13. North America Hospitals/Clinics Market By Region, From 2021 to 2026 ( USD Billion )
  14. North America Research Institutes Market By Region, From 2021 to 2026 ( USD Billion )
  15. North America Laboratory Centers Market By Region, From 2021 to 2026 ( USD Billion )
  16. United States Antiviral Drugs Market By Application, From 2021 to 2026 ( USD Billion )
  17. United States Antiviral Drugs Market By Target, From 2021 to 2026 ( USD Billion )
  18. United States Antiviral Drugs Market By End User, From 2021 to 2026 ( USD Billion )
  19. Canada Antiviral Drugs Market By Application, From 2021 to 2026 ( USD Billion )
  20. Canada Antiviral Drugs Market By Target, From 2021 to 2026 ( USD Billion )
  21. Canada Antiviral Drugs Market By End User, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample